Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia/lymphoma

ABSTRACT:

SUBMITTER: Suzuki S 

PROVIDER: S-EPMC12340079 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature